Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations
Program supports breast cancer and reconstruction research and education
SANTA BARBARA, Calif., Aug. 15, 2018 /PRNewswire/ -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that its FULL CIRCLE grant applications are now open for any U.S. based, nonprofit breast cancer organizations supporting breast cancer aid, research, patient outreach, advocacy, and prevention. The application period will end on September 15, 2018, and recipients will be announced by Sientra in October 2018.
Sientra FULL CIRCLE™ is a first-of its-kind charitable program aimed at aiding nonprofits in the breast cancer community who are committed to making a meaningful difference. The philanthropic initiative is supporting these organizations with the financial resources to fulfill their promising visions for the future - whether it is furthering research of breast cancer prevention, detection and treatment, or advancing educational efforts among the breast cancer and breast reconstruction community.
As part of the program, Sientra donates a portion of every OPUS™ breast tissue expander sale to the FULL CIRCLE fund. Currently, Sientra offers breast tissue expanders to provide more choices to meet the individualized needs of the patients, including: AlloX2®, the first and only breast tissue expander with access to the periprosthetic space to address fluid accumulation; and Dermaspan™, designed to provide a soft feel and desired outcomes.
"At Sientra, we believe that full commitment to a cause is about more than offering clinically-proven, safe and reliable products," said Jeff Nugent, Chairman and CEO at Sientra. "We will always support research and education on breast implant technology for surgeons and the women they serve, as well as support philanthropies focused on the research and treatment of patients with breast cancer. We are inspired by the work breast cancer organizations have done throughout the U.S. and are excited to give back to patients through FULL CIRCLE."
All applications will be evaluated by the FULL CIRCLE Steering Committee, a well-respected and independent team of board-certified plastic surgeons, with the goal of awarding grants to nonprofits committed to making a brighter future for the breast cancer community. The Committee is comprised of Dr. Peter Capizzi, Charlotte, NC; Dr. Troy Pittman, Washington, D.C.; and Dr. Kamakshi Zeidler, Silicon Valley, CA.
"I am excited about Sientra's FULL CIRCLE program - it is great to see the company's unique dedication to breast reconstruction patients by giving back to organizations who can make a difference," said Dr. Troy Pittman, one of FULL CIRCLE's Steering Committee members.
Sientra is the first and only medical aesthetics company to support an annual philanthropic program providing grants to nonprofit organizations focused on breast cancer issues. To apply for a Sientra FULL CIRCLE grant, please complete an application here: http://sientra.com/fullcircle/apply/.
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients' lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its OPUS™ breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry®, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.
Company Codes: NASDAQ-NMS:SIEN